LexBlog IP

OCTOBER 25, 2021

In March 2021, AbbVie, Inc. and AbbVie Biotechnology Ltd. (“AbbVie”) sued rival pharmaceutical company Alvotech hf. (“Alvotech”) for trade secret misappropriation under the federal Defend Trade Secrets Act (“DTSA”) and the Illinois Trade Secret Act. But the jurisdictional rules of U.S.

Intellectual Property 52

Intellectual Property Business Litigation Marketing 52

Fish & Richardson Trademark & Copyright Thoughts

OCTOBER 21, 2021

The investigation against them was initiated by the specialty product conglomerate Illinois Tool Works Inc. This case is an extension of our longtime work defending the intellectual property rights of Chinese companies in the U.S. Fish represented Guangzhou Rebenet Catering Equipment Manufacturing Co.,

Intellectual Property 52

Intellectual Property Litigation Trademark Patent 52

Trading Secrets

JUNE 3, 2022

In the case, a pharmaceutical company sued a former product development employee and his new employer in the District of New Jersey for misappropriation of trade secrets in violation of the DTSA. Similarly, in Five Star Gourmet Foods, Inc. Fresh Express, Inc. at *8; see also Payward, Inc. Contractors Inc.

Law 59

Law Confidentiality Designs Design 59

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

Several other companies have also announced plans to pursue interchangeable status for biosimilar products. Consistent with this, as shown below in Table 2, numerous companies have publicly announced the submission and/or acceptance of new biosimilar BLAs. Stimufend ® (Fresenius Kabi). Neulasta ® (Amgen). pegfilgrastim.

Litigation 52

Litigation Settlement Patent Marketing 52